Research output per year
Supervised work per year
Supervised Work
- 21 results
Search results
-
2025
AXL-erating the fight: conquering acute myeloid leukemia with single domain antibodies
Vandewalle, N., 2025, 186 p.Research output: Thesis › PhD Thesis
-
2024
Combining single-domain antibody-based targeted radionuclide therapy and immune checkpoint therapy to treat lung cancer
Ceuppens, H., 2024, 136 p.Research output: Thesis › PhD Thesis
-
Optimizing CAR-T cell therapy for multiple myeloma by exploiting the advantageous properties of VHH antigen-binding domains
Hanssens, H., 2024, 189 p.Research output: Thesis › PhD Thesis
-
Shedding light on tigit: optimization of nano-based tracers for nuclear imaging of a next-generation immune checkpoint
Zeven, K., 2024, 193 p.Research output: Thesis › PhD Thesis
-
Unraveling resistance mechanisms to immunotherapy in non-small-cell lung cancer
De Ridder, K., 2024, 192 p.Research output: Thesis › PhD Thesis
-
2023
Application of epigenetic-targeting agents to confer immune modulation in cancer
De Beck, L., 2023, Brussels: VUB Press. 247 p.Research output: Thesis › PhD Thesis
Open AccessFile349 Downloads (Pure) -
Developing the tools for an innovative personalized mRNA cancer vaccine
de Mey, W., 2023, 139 p.Research output: Thesis › PhD Thesis
Open AccessFile440 Downloads (Pure) -
Eccentric: Enhancing the function of cancer countering effector cells using nanobodies targeting regulatory immune checkpoints
Awad, R. M., 2023, 208 p.Research output: Thesis › PhD Thesis
File287 Downloads (Pure) -
Radiolabeled single-domain antibodies as a means to evoke and monitor immunological responses in malignant lesions
Ertveldt, T., 2023, 177 p.Research output: Thesis › PhD Thesis
Open AccessFile78 Downloads (Pure) -
S100A9: A therapeutic target in multiple myeloma and acute myeloid leukemia
Fan, R., 2023, 202 p.Research output: Thesis › PhD Thesis
-
Systemic cancer vaccination: tuning mRNA-LNP towards splenic uptake
Bevers, S., 2023, 165 p.Research output: Thesis › PhD Thesis
File585 Downloads (Pure) -
2022
In situ MRNA vaccination: bringing the fight to the tumor
Locy, H., 2022, 184 p.Research output: Thesis › PhD Thesis
Open AccessFile315 Downloads (Pure) -
2021
Developing nanobodies to advance immune checkpoint therapy that targets lymphocyteactivation gene 3
Lecocq, Q., 2021, 170 p.Research output: Thesis › PhD Thesis
Open AccessFile28 Downloads (Pure) -
TAMING cancer: TArgeting Myeloid cells using INnovative Gene-based technologies
De Vlaeminck, Y., 2021Research output: Thesis › PhD Thesis
-
2019
Evaluating single domain antibodies specific for PD-L1 as cancer nuclear imaging and therapy agents
Broos, K., 2019Research output: Thesis › PhD Thesis
-
2018
Myeloid-derived suppressor cells as a novel therapeutic target in colorectal cancer.
Dufait, I., 2018, Brussels: ASP / VUBPRESS. 164 p.Research output: Thesis › PhD Thesis
-
2016
ASPIRE: adjuvant-driven induction of cancer Specific Immune Responses
Van Der Jeught, K., 2016, Brussels.Research output: Thesis › PhD Thesis
-
2015
Targeting lentiviral vectors to antigen presenting cells
Goyvaerts, C., 2015, Brussels.Research output: Thesis › PhD Thesis
-
2014
Development of a local treatment modality for the systemic cure of cancer using mRNA as a medicinal product
Van Lint, S., 2014, Brussels.Research output: Thesis › PhD Thesis
-
2012
Lentiviral Vectors: A Versatile Tool to Evaluate Strategies to Fight Cancer
Emeagi, P., 2012, Brussels.Research output: Thesis › PhD Thesis
-
2005
HIV-1 derived lentiviral vectors as vehicles for cancer vaccination
Dullaers, M., 2005, Brussels.Research output: Thesis › PhD Thesis